<PAGE> 1
------------------------------
OMB APPROVAL
------------------------------
OMB Number: 3235-0145
Expires: October 31, 1994
Estimated average burden
Hours per response..... 14.90
------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 7)*
MICROSEMI CORP.
-----------------------------------------
(Name of Issuer)
COMMON STOCK
-----------------------------------------
(Title of Class of Securities)
595137100
-----------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 2
CUSIP NO. 595137100 13G PAGE 2 OF 3 PAGES
--------------------- ----- -----
(1) NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Froley, Revy Investment Co., Inc.
95-2931677
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
L.A., CA USA
------------------------------------------------------------------------------
(5) SOLE VOTING POWER
NUMBER OF NONE
SHARES --------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
OWNED BY NONE
EACH --------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH 863,330
--------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
NONE
--------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
844,880 owned in the form of 8,330 m CV Deb 5.875% 3/1/12
(conversion ration 73.801) and 71,964 common stock
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
-----------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
8.57%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON*
IA
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 3
CUSIP No. 595137100 PAGE 3 OF 3 PAGES
- ------------------- -----------------
ITEM #4
OWNERSHIP.
(a) Amount Beneficially Owned: 863,330
(b) Percent of Class: 8.57%
(c) Number of Shares as to which such person has:
(i) sole power to vote or to direct the vote: NONE
(ii) shared power to vote or to direct the vote: NONE
(iii) sole power to dispose or to direct the disposition of: 863,330
(iv) shared power to dispose or to direct the disposition of: NONE
ITEM #10
- --------
CERTIFICATION: By signing below I certify that, to the best of my
knowledge and belief, the securities referred to
above were acquired in the ordinary course of
business and were not acquired for the purpose of
and do not have the effect of changing or influencing
the control of the issuer of such securities and were
not acquired in connection with or as a participant in
any transaction have such purposed or effect.
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
- ---------------------------- -------------------------
Andrea O'Connell Date
Managing Director
Froley, Revy Investment Co., Inc.
